Logistics & Supply Chains

Scroll Down To Discover

DHL Supply Chain Reports 12% Growth in Sustainable Revenue

As geopolitical uncertainty, changing trade patterns, and technological development reshape global supply chains, companies are increasingly looking for long-term logistics partners that can provide resilience and combine global scale, sector expertise, and technology. This shift is creating new opportunities for DHL Supply Chain, DHL Group's contract logistics business. In the third quarter of 2026, reported revenue increased by 12.0% year-on-year, with growth across all regions: 13.1% in the Americas, 11.7% in Europe, the Middle East and Africa (EMEA), and 9.9% in Asia Pacific. Growth spans across sectors including life sciences and healthcare, new energy, technology, retail, consumer, and automotive.

“Supply chain resilience has become a strategic differentiator for many companies,” said Hendrik Venter, CEO, DHL Supply Chain. “Our customers have to manage greater complexity while improving resilience to supply disruptions, productivity, and flexibility. They need long-term partners that understand their industries, can scale proven technology in operations, and have the capability to provide end-to-end supply chain solutions across global markets. The growth we are seeing across regions and sectors shows that this approach is resonating with our customers.”

DHL Supply Chain continues to invest in identified high-growth markets, long-term partnerships, and strategic sector-specific initiatives. These investments include AI and robotics, automation, and acquisitions. Recent examples range from expanding Life Sciences and Healthcare capabilities in Latin America and the United States to specialized capacity for emerging industries such as battery logistics.

In Life Sciences and Healthcare, DHL Supply Chain has progressively expanded its partnership with Sanofi, from managing logistics operations at three key distribution sites since 2024 to taking over operations at the company's vaccine distribution center in Val-de-Reuil in 2026. The expanded partnership illustrates how specialized logistics capabilities and an international network can support pharmaceutical companies as they transform critical supply chains. In parallel, numerous newly built multi-user pharmaceutical warehouses are being commissioned, further expanding DHL Supply Chain’s global footprint of more than 250 pharmaceutical warehouses.

In the technology sector, the rapid expansion of AI and digital infrastructure is creating new logistics requirements. Data center logistics require specialized, globally integrated end-to-end supply chain solutions, including white-glove services. DHL Supply Chain is expanding its business across this wider ecosystem, supporting operators, technology providers, and infrastructure partners in developing data center capacity.

“For our customers, choosing a logistics partner is a long-term strategic decision,” said Andries Retief, Chief Development Officer, DHL Supply Chain. “They are entrusting us with critical parts of their operations and relying on us to support their future growth. Our ability to combine global scale, deep industry expertise, operational excellence, and innovation is what differentiates DHL Supply Chain. The strength of our commercial performance reflects customers' confidence in our ability to deliver today while helping them build the supply chains they will need tomorrow.”

Prev Post CargoAi Launches CargoQUALITY
You may also like

Please subscribe in order to view the E-Magazine

or

You can login to your account.

Login
or

You can subscribe to get the access.

Subscribe